rs58597584
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000226.4(KRT9):c.469A>G(p.Met157Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M157R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000226.4 missense
Scores
Clinical Significance
Conservation
Publications
- epidermolytic palmoplantar keratoderma, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
- -
The M157V variant in the KRT9 gene has been reported previously using alternate nomenclature (M156V) in association with epidermolytic palmoplantar keratoderma (EPPK) (Hennies et al., 1994; Covello et al., 1998; Rugg et al., 2002). The M157V variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The M157V variant is a conservative amino acid substitution and occurs within a known mutational hotspot region (helix initiation motif) that is highly conserved across all species and among all members of the keratin family. Missense variants at the same residue (M157R, M157K, M157T) and in nearby residues (L160V, L160F, L160P, N161Y, N161H, N161S, N161I, N161K) have been reported in the Human Gene Mutation Database in association with EPPK (Stenson et al., 2014), supporting the functional importance of this region of the protein. It is well established that keratin gene mutations affecting the residues at the ends of the central rod domains of the keratin proteins (helix initiation and termination motifs) interfere with proper keratin intermediate filament assembly and function, resulting in skin fragility and/or hyperkeratosis (Chamcheu et al., 2011). Therefore, we interpret M157V as a pathogenic variant. -
For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT9 protein function. ClinVar contains an entry for this variant (Variation ID: 3002). This variant is also known as c.466A>G (p.Met156Val); c.532A>G (p.Met156Val). This missense change has been observed in individuals with epidermolytic palmoplantar keratoderma (PMID: 7516304, 9856842). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 157 of the KRT9 protein (p.Met157Val). -
Epidermolytic palmoplantar keratoderma, 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at